Related Experiment Video

Updated: Mar 10, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

6.1K

Preventative Cardiology in Cardio-Rheumatology Clinics: Medication Toxicity and Screening Considerations for Women of

Rashmi Dhital1, Adenrele A Olajide2, Bruno B Lima3

  • 1Department of Medicine, Division of Rheumatology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.

The American Journal of Cardiology
|March 9, 2026
PubMed

Insights

Cardio-rheumatology clinics improve care by integrating data and imaging. However, specific guidelines are lacking for women of childbearing potential with rheumatic diseases regarding cardiovascular disease risk reduction.

Area of Science:

  • Cardiology
  • Rheumatology
  • Preventive Medicine

Background:

  • Cardio-rheumatology clinics integrate advanced imaging and data analysis for disease understanding and personalized medicine.
  • Preventive cardiology for women of childbearing potential necessitates careful attention to medication toxicity and screening.
  • Individuals with rheumatic diseases face unique cardiovascular disease (CVD) risks.

Purpose of the Study:

  • To review how cardio-rheumatology clinics manage CVD risk reduction in patients with rheumatic diseases.
  • To identify specific recommendations for women of childbearing potential within this population.
  • To highlight gaps in current clinical practice guidelines.

Main Methods:

  • A narrative review of published cardio-rheumatology literature was conducted.
  • Literature search focused on the term "cardio-rheumatology".
  • Articles were reviewed for recommendations pertinent to women of childbearing potential.

Main Results:

  • Current literature addresses traditional CVD risk assessments, imaging, and laboratory screening.
  • No specific clinical practice guidelines were found for women of childbearing potential with rheumatic diseases.
  • Existing reproductive health guidelines lack dedicated cardio-rheumatology preventative recommendations.

Conclusions:

  • Cardio-rheumatology clinics play a vital role in addressing CVD risk in rheumatic diseases.
  • There is a critical need for specific guidelines for women of childbearing potential with rheumatic diseases.
  • Further research and guideline development are essential for this vulnerable population.

Keywords:
atherosclerosiscardio-rheumatologycardiovascular diseasesdrug-related side effectsplacentaprimary preventionrheumatology

More Related Videos

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.2K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

9.3K

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
68
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
440
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
400
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
848
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
306
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K